National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, & ebrary, Inc. (2011). Risk-characterization framework for decision-making at the food and drug administration. National Academies Press.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, y Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. Washington, DC: National Academies Press, 2011.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
National Research Council (U.S.). Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, y Inc ebrary. Risk-characterization Framework for Decision-making at the Food and Drug Administration. National Academies Press, 2011.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.